Pediatric Headache Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Headache. 2021 Nov;61(10):1475-1492. doi: 10.1111/head.14236. Epub 2021 Dec 4.
The goal of this paper is to provide a compilation of the evidence for the treatment of posttraumatic headache (PTH) in the pediatric population. Headache features and timing of therapy were considered.
Headache is the most common symptom following mild traumatic brain injury (mTBI), affecting more than 80% of children and adolescents. It is unclear whether treatment for PTH should be tailored based on headache characteristics, particularly the presence of migraine features, and/or chronicity of the headache.
Systematic literature searches of PubMed, Embase, Scopus, and Cochrane databases (1985-2021, limited to English) were performed, and key characteristics of included studies were entered into RedCAP (Prospero ID CRD42020198703). Articles and conference abstracts that described randomized controlled trials (RCTs), cohort studies, retrospective analyses, and case series were included. Participants included youth under 18 years of age with acute (<3 months) and persistent (≥3 months) PTH. Studies that commented on headache improvement in response to therapy were included.
Twenty-seven unique studies met criteria for inclusion describing abortive pharmacologic therapies (9), preventative pharmacotherapies (5), neuromodulation (1), procedures (5), physical therapy and exercise (6), and behavioral therapy (2). Five RCTs were identified. Studies that focused on abortive pharmacotherapies were completed in the first 2 weeks post-mTBI, whereas other treatment modalities focused on outcomes 1 month to over 1-year post-injury. Few studies reported on migrainous features (7), personal history of migraine (7), or family history of migraine (3).
There is limited evidence on the timing and types of therapies that are effective for treating PTH in the pediatric population. Prospective studies that account for headache characteristics and thoughtfully address the timing of therapies and outcome measurement are needed.
本文旨在为儿科人群创伤后头痛(PTH)的治疗提供证据综述。本文考虑了头痛的特征和治疗时机。
头痛是轻度创伤性脑损伤(mTBI)后最常见的症状,影响 80%以上的儿童和青少年。目前尚不清楚针对 PTH 的治疗是否应根据头痛特征(尤其是偏头痛特征的存在)和/或头痛的慢性程度进行调整。
对 PubMed、Embase、Scopus 和 Cochrane 数据库(1985-2021 年,仅限于英语)进行系统文献检索,并将纳入研究的关键特征输入 RedCAP(Prospero ID CRD42020198703)。本文纳入了描述随机对照试验(RCT)、队列研究、回顾性分析和病例系列的文章和会议摘要。参与者包括年龄在 18 岁以下的急性(<3 个月)和持续性(≥3 个月)PTH 患者。本文纳入了评论治疗后头痛改善的研究。
27 项符合纳入标准的独特研究描述了发作性药物治疗(9 项)、预防性药物治疗(5 项)、神经调节(1 项)、手术(5 项)、物理治疗和运动(6 项)以及行为治疗(2 项)。本文共确定了 5 项 RCT。侧重于发作性药物治疗的研究在 mTBI 后 2 周内完成,而其他治疗方法侧重于损伤后 1 个月至 1 年以上的结果。少数研究报告了偏头痛特征(7 项)、偏头痛个人史(7 项)或偏头痛家族史(3 项)。
目前针对儿科人群 PTH 的治疗时机和治疗方法的证据有限。需要进行前瞻性研究,考虑头痛特征,并认真解决治疗时机和结果测量问题。